MicroRNA Market to Grow with a CAGR of 12.19% through 2028
Rising
prevalence of chronic diseases is expected to drive the Global MicroRNA Market
growth in the forecast period, 2024-2028.
According to
TechSci Research report, “MicroRNA Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global
MicroRNA Market stood at USD 1548.17 Million in 2022 and is anticipated to grow
with a CAGR of 12.19% in the forecast period, 2024-2028. A primary driver
behind the growth of the Global MicroRNA Market is the escalating prevalence of
chronic diseases worldwide. MiRNAs have demonstrated immense potential as
biomarkers for diseases such as cancer, cardiovascular disorders, and
neurological conditions. Their ability to reflect the molecular intricacies of
these diseases has positioned them as invaluable tools for early diagnosis,
prognosis, and personalized treatment plans.
The landscape of
miRNA research has been transformed by remarkable advancements in sequencing
and profiling technologies. High-throughput sequencing techniques have allowed
researchers to identify and profile miRNAs with unprecedented speed and
accuracy. This has not only facilitated comprehensive studies on miRNA
expression patterns but has also enabled the development of more targeted
diagnostic tools and therapeutic interventions.
MicroRNAs have
become integral components of diagnostic strategies, playing a crucial role in
the era of personalized medicine. The ability of miRNAs to provide insights
into the underlying molecular mechanisms of diseases has led to their
incorporation into diagnostic assays for various conditions. Their presence as
biomarkers in liquid biopsies has opened new avenues for non-invasive
diagnostic approaches, revolutionizing the way diseases are detected and
monitored.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global MicroRNA Market”
The Global
MicroRNA Market is segmented into Products & Services, End-Use, Application, Regional Distribution, And Company.
Based on the
Products & Services, services emerged as the dominant segment in the global
market for Global MicroRNA in 2022. Research
and development initiatives focusing on microRNA-based applications, such as
biomarker discovery and therapeutic interventions, have intensified, fostering
a robust market for specialized services. The comprehensive support provided by
service providers in navigating the challenges associated with miRNA research,
including sample processing, data interpretation, and assay optimization, has
positioned services as an integral component of the Global MicroRNA Market.
This trend reflects the industry's recognition of the value-added by expert
services in advancing the understanding and application of microRNAs in diverse
biomedical fields.
Based
on the End-Use, academic & government research institutes emerged as the
dominant segment in the global market for Global MicroRNA Market in 2022. The dominance of this segment is fueled by the relentless
pursuit of knowledge in miRNA research, with a focus on biomarker discovery,
disease profiling, and exploring therapeutic applications. These institutions
act as hubs for innovation, fostering collaborations, and driving advancements
in sequencing technologies, bioinformatics, and experimental methodologies
related to miRNA studies. Additionally, government funding and grants often
support miRNA research initiatives within these institutions, providing the
necessary resources for comprehensive investigations. The academic and
government research institutes' dominance underscores their crucial role in
laying the foundation for the broader applications of miRNAs in diagnostics and
therapeutics. As they continue to spearhead pioneering studies, the Global
MicroRNA Market is poised to benefit from the insights and discoveries emerging
from these academic and government research hubs.
Based on the
Application, cancer segment emerged as the dominant segment in the global
market for Global MicroRNA Market in 2022. This is due to the recognition of
miRNAs as crucial players in cancer biology, influencing key processes such as
cell proliferation, apoptosis, and metastasis. The unique miRNA signatures
associated with different cancer types make them valuable biomarkers for early
detection, prognosis, and monitoring treatment responses. Researchers and
clinicians are increasingly leveraging miRNAs to unravel the complexities of
cancer biology, identifying specific miRNA profiles indicative of different
stages and subtypes of cancer. The potential of miRNAs as diagnostic tools
extends to liquid biopsies, where circulating miRNAs offer a non-invasive
approach to cancer detection.
The
North American region has been at the forefront of technological innovation in
healthcare, including diabetes management. This regional dominance is
attributed to a confluence of factors that contribute to the robust growth and
advancement of the microRNA sector. The well-established presence of leading
pharmaceutical and biotechnology companies, coupled with a sophisticated
healthcare infrastructure, positions North America at the forefront of microRNA
research and commercialization. The region's strong emphasis on research and
development, particularly in the field of molecular diagnostics and
personalized medicine, has fueled substantial investments in microRNA-related
initiatives. Academic and research institutions, coupled with substantial
government funding, contribute significantly to the region's expertise in
unraveling the complexities of microRNA biology and its applications.
Major companies
operating in MicroRNA Market are:
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Horizon Discovery Ltd.
- Synlogic
- QIAGEN
- GeneCopoeia, Inc.
- New England Biolabs
- Quantabio
- NanoString
Download Free Sample Report
Customers can
also request for 10% free customization
on this report
“The Global
MicroRNA Market is poised for robust growth in the coming years. Anticipated
advancements in sequencing technologies, particularly next-generation
sequencing, will provide researchers with unprecedented insights into the
intricacies of microRNA biology, fostering a deeper understanding of their
roles in health and disease. The rising trend of liquid biopsies, fueled by the
non-invasive nature of miRNA detection in bodily fluids, is expected to gain
further traction, revolutionizing disease diagnostics and monitoring. Additionally,
the continued exploration of miRNA-based therapeutics and the integration of
artificial intelligence in miRNA research are poised to unlock new dimensions
in precision medicine and personalized healthcare. Strategic collaborations
between academia, pharmaceutical companies, and biotechnology firms are likely
to catalyze innovation and accelerate the translation of microRNA discoveries
into clinical applications”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“MicroRNA
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028 Segmented By Products & Services (Instruments, Consumables,
Services ), By Application (Cancer, Infectious Diseases, Immunological
Disorder, Cardiovascular Disease, Neurological Disease, Others), By End-Use
(Biotechnology & Pharmaceutical Companies, Academic & Government
Research Institutes, Other end-users) Region and Competition”,
has evaluated the future growth potential of Global MicroRNA Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global MicroRNA Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com